NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options
Oslo, 30 September 2020: The board of directors of Navamedic ASA (the "Company"), has today, on 30 September 2020, pursuant the authorisation granted to it by the general meeting on 3 June 2020, resolved to increase the Company's share capital by NOK 92,500 by issuance of 125,000 new shares, each with a nominal value of NOK 0.74, in order to facilitate today's exercise of 125,000 share options by the Company's CEO, Kathrine Gamborg Andreassen. The exercised share options were granted in May 2019 and have, following the completion of the demerger in October 2019, a strike price of NOK 8.88